Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
With the use of HCQ at stable doses of 200 mg/day (or 3.0-3.5 mg/kg/day) as the background therapy in patients with systemic lupus erythematosus, the majority of patients achieved prolonged remission.
Authors
- Guillermo Ruiz‐Irastorza (ORCID: https://orcid.org/0000-0001-7788-1043)
- Laura Amo
- Ioana Ruiz‐Arruza
- Fernando Arizpe
- D. Paredes (ORCID: https://orcid.org/0000-0001-8378-8638)
- Valerio Campos‐Rodríguez (ORCID: https://orcid.org/0009-0008-0395-4367)
- Víctor Moreno‐Torres (ORCID: https://orcid.org/0000-0002-9798-4514)
- Daniel Martín‐Iglesias (ORCID: https://orcid.org/0000-0001-8476-0725)
Institutions
- Ikerbasque (ES)
- University of the Basque Country (ES)
- BioCruces Health research Institute (ES)
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
- Universidad Internacional De La Rioja (ES)
- Hospital Italiano La Plata (AR)
- Santa Lucía University General Hospital (ES)
Publication Details
- Journal
- Lupus Science & Medicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1136/lupus-2024-001254
- Citations
- 5
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 6.67
Funders
- Eusko Jaurlaritza